论文部分内容阅读
目的:评估结核抗体(TBAb)对结核病的诊断价值。方法:采用酶联免疫吸附(ELISA)试验法测定231例结核患者、170例非结核病及健康人的血清TBAb或体腔液的TBAb。结果:结核组中血清TBAb阳性率为76.6%,非结核病及健康人组中的阳性率为9.4%,两组差异有显著性(P<0.01)。结核性体腔液TBAb阳性率为85.9%,非结核性体腔液阳性率为5.0%,差异有显著性(P<0.005)。结论:ELISA法检测TBAb是诊断肺结核及肺外结核的一项有效的辅助诊断手段。同时进行血清及体腔液的TBAb测定,可提高结核的诊断率。
Objective: To evaluate the diagnostic value of tuberculosis antibody (TBAb) to tuberculosis. Methods: The enzyme-linked immunosorbent assay (ELISA) was used to determine the TBAb in 231 TB patients and 170 non-TB patients and healthy volunteers. Results: The positive rate of TBAb in tuberculosis group was 76.6%, and that in non-tuberculosis and healthy people was 9.4%. There was significant difference between the two groups (P <0.01). Tuberculous body fluid TB Ab positive rate was 85.9%, non-tuberculous body fluid positive rate was 5.0%, the difference was significant (P <0.005). Conclusion: ELISA TB-Ab is an effective diagnostic tool for the diagnosis of tuberculosis and extrapulmonary tuberculosis. At the same time serum and body fluid TB Ab determination, can improve the diagnostic rate of tuberculosis.